July 31, 2023
Conclusion of the agreement in the area of securing venetoclax supply chain for RVU120 Phase II clinical trial in combination therapy in hematology
Year
2023
Assets in this page
Download assets
- pdf file
Current Report ESPI 37/2023
Download